Boston Scientific Recalls OverStitch Suture Cinch Over Deployment Failure Risk
FDA classifies recall of endoscopic tissue approximation device as Class II due to potential failure to deploy cinch or cut suture.
Every recalls & safety alerts report published for Massachusetts, newest first.
FDA classifies recall of endoscopic tissue approximation device as Class II due to potential failure to deploy cinch or cut suture.
The FDA has classified the recall of certain lots of the Emit 2000 Quinidine Assay as Class II, and is urging users to check their inventory against the listed lots and UDI.
FDA classifies recall of 1,445 portable renal perfusion systems as Class II due to potential loss of displayed preservation parameters.
FDA classifies recall of Syva EMIT 2000 Quinidine Assay as Class II due to risk of elevated measurements.
The FDA has closed the recall of Spectra Medical Devices' Sodium Chloride Injection, 0.9%, USP 10mL Ampule, citing completed corrective actions.
The FDA has reported a Class II recall of certain Straumann Bone Level Tapered implants that may be shorter than labeled, as of August 19, 2026.
FDA enforcement records show an ongoing recall of four GEM Premier 7000 portable blood analyzers due to barcode reader wand issues.
The ongoing recall covers 42 IQon Spectral CT units and upgrades distributed across the United States and Puerto Rico.
The agency considers the recall of 67 portable blood analyzer systems carried out.
The agency considers the recall carried out for 27 blood analyzer units involved in a barcode reader identification issue.
The FDA classified the recall of 21 GEM Premier 5000 blood analyzer systems as Class II on August 5, 2026.
Instrumentation Laboratory has recalled 109 units of GEM Premier 5000 PAK due to solution concentration issues.
An ongoing Class II recall covers 322,450 flexible food pouches that may release thin plastic strips into food puree.
Boston Scientific Corporation initiated an ongoing recall for thousands of biopsy forceps due to a potential packaging breach.
An FDA enforcement report covering 87,277 units cites potential introducer sheath leakage that the record says is not visually detectable by users.
An enforcement report covering 846 units of the 14 Fr introducer kit cites a potential for sheath leakage that the record says is not visually detectable by users.
An FDA enforcement report lists 1,540 units of the 14 Fr introducer kit recalled worldwide over a potential sheath leakage issue that the record says is not visible to users.
An FDA enforcement report classifies the ongoing Class II recall of more than 150,000 US units of the endoscopy injection set, citing a recalled component syringe that may loosen from the manifold.